Implications of a predicted autoimmune disease on the COVID-19 pandemic, potential risks of White Lung Syndrome, and lessons from past pandemics.
-
Dr. Philip McMillan predicted a viral-mediated autoimmune disease in early 2020, impacting disease treatment and vaccination campaigns. • 0:04
-
Concerns raised about the potential risks of White Lung Syndrome and the seriousness of the situation. • 1:13
-
Comparison drawn to the 1918 pandemic, highlighting the possibility of significant increase in death toll if mistakes are repeated. • 2:13
-
Prediction of a potential tsunami of deaths, urging quick action to mitigate the impact. • 2:43
-
Hope to reduce deaths by 10-15% through serious scientific efforts and community collaboration. • 3:10
-
Emphasis on the need for acknowledgment and work by the entire scientific community to address the situation. • 3:29
-
Reference to a news story in the Daily Mail discussing Denmark’s situation related to the topic. • 3:47
Global surge in white lung syndrome cases caused by micoplasma pneumonia, raising concerns about vaccine development and transmission blocking.
-
White lung syndrome cases increasing globally due to micoplasma pneumoni. • 3:54
-
Health emergency may be declared in Denmark due to significant rise in case. • 4:51
-
Concerns raised about vaccine development triggering hypersensitivity immune pathology in lung. • 6:05
-
Previous vaccine candidates failed to block transmission effectivel. • 7:01
Study from 2012 raises concerns about immune response to SARS vaccines and challenges in achieving herd immunity.
-
Study in 2012 showed that SARS vaccines induced antibody protection but also led to immune pathology when challenged with live virus. • 7:33
-
Achieving herd immunity may be a challenge due to significant circulation of SARS COV-2. • 7:40
-
Initial immune response is important, but outcomes upon further exposure to the virus must also be considered. • 9:47
-
Significant circulation of SARS COV-2 indicates a challenge in achieving herd immunity. • 10:11
-
Challenge study exposed the whole population to the virus after vaccination and natural immunity. • 10:21
-
Caution was advised in proceeding with SARS COV-2 vaccine in humans due to potential hypersensitivity to virus components. • 11:13
-
mRNA vaccines were pushed as a potential solution to immune pathology concerns. • 11:31
Implications of ongoing virus circulation leading to hypersensitivity pneumonitis and challenges in treatment.
-
Ongoing virus circulation leads to hypersensitivity pneumoniti. • 11:55
-
Exposure to triggers can result in allergic inflammatory lung proces. • 13:20
-
Chronic exposure may lead to lung fibrosi. • 14:02
-
Difficulty in reducing exposure to allergens due to uncontrolled virus sprea. • 14:19
-
No easy solutions due to high infection rates and challenges in controlling the viru. • 14:51
-
Treatment involves immune suppression with long-term risk. • 15:11
-
Long-term implications of immune suppression across the populatio. • 15:26
Implications of a severe lung condition, urgent need for research and action, and concerns over escalating pandemic.
-
Urgent need for global priority in researching lung histology and eosinophil respons. • 15:58
-
Importance of transparency and seriousness in addressing the severity of the situatio. • 16:48
-
Critical questions on managing virus circulation and reducing exposure to prevent further escalatio. • 17:03
-
Concern over potential repetition of pandemic with escalating numbers and need for vigilanc. • 17:20
-
Call for scientific community to focus on finding solutions and making a differenc. • 17:51
-
Continued monitoring of scientific developments and hope for positive outcome. • 18:27